Found: 6
Select item for more details and to access through your institution.
Effectiveness and safety of eribulin for human epidermal growth factor receptor 2 negative metastatic breast cancer in a real-world population.
- Published in:
- Journal of Oncology Pharmacy Practice, 2022, v. 28, n. 7, p. 1573, doi. 10.1177/10781552211038241
- By:
- Publication type:
- Article
Cost of Venous Thromboembolic Disease in Patients with Lung Cancer: COSTECAT Study.
- Published in:
- International Journal of Environmental Research & Public Health, 2021, v. 18, n. 2, p. 394, doi. 10.3390/ijerph18020394
- By:
- Publication type:
- Article
A multi-criteria decision analysis on the value of nintedanib for interstitial lung diseases.
- Published in:
- International Journal of Technology Assessment in Health Care, 2022, v. 38, n. 1, p. 1, doi. 10.1017/S0266462322000459
- By:
- Publication type:
- Article
A multi-criteria decision analysis on the value of nintedanib for interstitial lung diseases.
- Published in:
- International Journal of Technology Assessment in Health Care, 2021, v. 38, n. 1, p. 1, doi. 10.1017/S0266462322000459
- By:
- Publication type:
- Article
Role of Isolated Limb Perfusion in the Era of Targeted Therapies and Immunotherapy in Melanoma. A Systematic Review of The Literature.
- Published in:
- Cancers, 2021, v. 13, n. 21, p. 5485, doi. 10.3390/cancers13215485
- By:
- Publication type:
- Article
Recent Advances in the Management of Patients with Non-Muscle-Invasive Bladder Cancer Using a Multidisciplinary Approach: Practical Recommendations from the Spanish Oncology Genitourinary (SOGUG) Working Group.
- Published in:
- Cancers, 2021, v. 13, n. 19, p. 4762, doi. 10.3390/cancers13194762
- By:
- Publication type:
- Article